A survey of five antidepressant properties influencing clinician's treatment choices in MDD

Neuropsychiatric Disease and Treatment

Volumn 3, Issue 1, 2007, Pages 169-172

  Papakostas, George I ^a   Hallett, Lindsay A ^a   Smith, Juliana ^a   Tossani, Eliana ^a   Mascarini, Alessandra ^a   Burns, Alana M ^a   Birnbaum, Robert J ^a   Fava, Maurizio ^a   Alpert, Jonathan E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antidepressant; Depression; Preferences; Prescribing; Survey

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEALTH SURVEY; HUMAN; MAJOR DEPRESSION; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; PRESCRIPTION; PROFESSIONAL PRACTICE; PSYCHOPHARMACOLOGY; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

EID: 34249043253     PISSN: 11766328     EISSN: None     Source Type: Journal    
DOI: 10.2147/nedt.2007.3.1.169     Document Type: Article

References (9)

1. [APA] American Psychiatric association. 2000. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry, 2000:157.
2. Cipriani A, Barbui C, Brambilla P, et al. 2006. Are all antidepressants really the same? The case of fluoxetine: a systematic review. J Clin Psychiatry, 67:850-64.
3. Garrison GD, Levin GM. 2000. Factors affecting prescribing of the newer antidepressants. Ann Pharmacotherapy, 34:10-14.
4. Hickie IB, Scott EM, Davenport TA. 1999. Are antidepressants all the same? Surveying the opinions of Australian psychiatrists. Aust N Z J Psychiatry, 33:642-9.
5. Mulrow CD, Williams JW Jr, Trivedi M, et al. 1999. Treatment of depression - newer pharmacotherapies. Evid Rep Technol Assess (Summ), 7:1-4.
6. Olfson M, Marcus SC, Pincus HA, et al. 1998. Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry, 55:310-16.
7. Papakostas GI, Fava M. 2006. Does the probability of receiving placebo influence the likelihood of responding to placebo or clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Neuropsychopharmacology, 31(s1):s158.
8. Petersen T, Dording C, Neault NB, et al. 2002. Survey of prescribing practices in the treatment of depression. Prog NeuroPsychopharmacol Biol Psychiatry, 1: 177-87.
9. Walsh BT, Seidman SN, Sysko R, et al. 2002. Placebo response in studies of major depression: variable, substantial, and growing. JAMA, 287:1840-7.